,i #aaith ,,congress #ast ,session ,h4 ,r4 #bedb ,,in ,,the ,,house ,,of ,,representatives ,april #a1 #bjbe,mr4 ,davis of ,north ,carolina 7for himself and ,mr4 ,pfluger7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend titles ,,xviii and ,,xix of the ,social ,security ,act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the ,medicare and ,medicaid programs1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,old ,drugs1 ,new ,cures ,act4 #b4 ,priority research drugs 7a7 ,in general ,section #aibg7;c77#b77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7;c77#b77;,c77 is amended by inserting the following new clause before the flush matter at the end3 7iv7 ,priority research drug 7,i7 ,request for designation ,not later than #ij days following the date of enactment of this clause1 the ,secretary shall establish and make effective a process for the manufacturer of a covered outpatient drug to request that the ,secretary designate the drug as a priority research drug4 7,,ii7 ,designation ,not later than #fj calendar days after the receipt of a request under subclause 7,i71 the ,secretary shall designate a covered outpatient drug as a priority research drug so long as it meets the following criteria3 7aa7 ,as of the date of submission of such request1 at least #aj years have elapsed since the date the drug was approved under section #eje7;c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act or section #cea7;a7 of the ,public ,health ,service ,act4 7bb7 ,the manufacturer of the drug is investigating such drug under section #eje7;i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act or section #cea7;a77#c7 of the ,public ,health ,service ,act for a new indication that would address a significant unmet medical need because there is no alternative drug approved under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act or licensed under section #cea of the ,public ,health ,service ,act for such indication on the date that the request under subclause 7,i7 was submitted to the ,secretary4 7cc7 ,the new indication described in item 7bb7 is for a disease or condition that has a high prevalence among beneficiaries of ,federal health care programs4 ,for purposes of this clause1 a disease or condition has a high prevalence among beneficiaries of ,federal health care programs if at least #cc percent of claims in the population targeted by the new indication during the prior calendar year were paid for under-- 7,,aa7 a ,state plan under this title or a ,state child health plan under title ,,xxi2 7,,bb7 part ,d of title ,,xviii with respect to an individual who is eligible for subsidies under section #ahfj;,d-#ad2 7,,cc7 the drug discount program under section #cdj;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b2 or 7,,dd7 a health care program administered by the ,department of ,veterans ,affairs4 4 7b7 ,exclusion of priority research drugs from ,medicaid definition of line extension ,the flush matter at the end of section #aibg7;c77#b77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7;c77#b77;,c77 is amended by inserting a priority research drug 7as designated under clause 7iv77 or after does not include4 7c7 ,exclusion of priority research drugs from ,medicaid best price special rule for selected drugs ,section #aibg7;c77#a77;,c77ii77,v7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7;c77#a77;,c77ii77,v77 is amended by inserting unless such drug is also designated as a priority research drug under paragraph 7#b77;,c77iv7 during such period before the period4 7d7 ,exclusion of priority research drugs from ,medicare definition of line extension ,section #ahfj;,d-#ad;,b7b77#e77;,b77ii7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aad;b7b77#e77;,b77ii77 is amended by inserting a priority research drug 7as designated under section #aibg7;c77#b77;,c77iv77 or after does not include4